General
Pfizer says trials show COVID-19 antiviral pill cuts hospitalisation and death risk by nearly 90 per cent
Pfizer says its experimental antiviral pill for COVID-19 cut rates of hospitalisation and death by nearly 90 per cent in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.
Key points:
- Pfizer says preliminary results of its study show its…
Continue Reading
-
Business17 hours ago3 of the best ASX shares to buy with $5,000
-
Noosa News16 hours agoElderly pair killed in rural highway intersection crash with caravan
-
Business13 hours agoUp 29% since April, why is this ASX 200 coal stock tumbling today?
-
Business9 hours agoWhy 29Metals, Atlas Arteria, DroneShield, and Yancoal shares are falling today